Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

CEL-SCI Corp

CEL-SCI Corp

CVM · NYSE MKT
CVM · NYSE MKT

Next Earnings: 12 Aug 2025

2.38
USD0.073.03%

Latest News

    CoinOtag

    Brazil Could Launch First Spot XRP ETF Following Regulatory Approval from CVM

      CryptoGlobe

      $SOL: Brazil’s CVM Approves Second Solana ETF as U.S. Regulators Hesitate

        Cryptopolitan

        Brazil’s CVM greenlights the first Solana ETF

          Bitcoin.com

          Brazilian Securities Regulator CVM Initiates Inquiry Into Tokenization Operations

            Bitcoin.com

            CVM Chief: Brazilian CBDC Drex to ‘Kill’ Many Cryptocurrencies

              Cryptopolitan

              Brazil’s CVM to pioneer tokenization use cases in 2024 regulatory sandbox

              Hold

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              2.25USD
              2.40USD

              52 Week Range

              0.18USD
              207.00USD

              Market Cap

              12.38MUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              NYSE MKT

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US1508377066

              CUSIP

              150837409

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              September

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -

              Book Value

              2.85

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -12.4

              Wall Street Target Price

              240.02

              EPS Estimate Current Year

              -12.30

              EPS Estimate Next Year

              -

              EPS Estimate Current Quarter

              0

              EPS Estimate Next Quarter

              0

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              28,558

              Gross Profit TTM

              -17,624,736

              EBITDA

              -23,937,078

              Profit Margin

              0.00%

              Return On Assets TTM

              -62.86%

              Return On Equity TTM

              -244.56%

              Revenue Per Share TTM

              0.001

              Qtly Revenue Growth YOY

              -62.70%

              Diluted Eps TTM

              -12.4

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              11797.424

              Price Book MRQ

              0.9329

              Enterprise Value Revenue

              0

              Enterprise Value EBITDA

              -3

              Peers analysis

              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                494.60

                2.43%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                450.31

                1.46%
              • argenx NV ADR
                ARGXargenx NV ADR

                585.93

                1.01%
              • Be
                ONCBeiGene, Ltd.

                258.00

                0.39%
              • UCB SA
                UCBJFUCB SA

                179.39

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                151.50

                -4.36%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                299.84

                -2.58%
              • BioNTech SE
                BNTXBioNTech SE

                108.54

                -1.40%
              • UCB SA ADR
                UCBJYUCB SA ADR

                92.59

                -0.28%
              • CSL Ltd
                CSLLYCSL Ltd

                78.96

                -0.15%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is CEL-SCI Corp stock price today?

              What is CEL-SCI Corp stock ticker?

              Is CVM stock price going up?

              What is the analyst recommendation for CVM?

              What is CVM market cap?

              Does CVM release financial reports?

              When is CVM next earnings date?

              What were CVM Earnings for the last quarter?

              What was CVM Revenue for the last quarter?

              What was CVM Net Income for the last quarter?

              Does CVM pay dividends?

              How many employees does CVM have?

              What is CVM EBITDA?

              How to buy CVM stocks?

              Should I invest in CVM stock?